Practo Invests $30 Million To Expand into 35 Indian Cities
Health Care startup Practo technologies have big plans to expand to 35 Indian cities and more than six international […]
Health financing insurance
Government mulling NHM to reduce common man’s expenditure on health
The Indian government is mulling a national health mission to reduce the common man’s spending on health care. A group […]
Sun Pharma hits record high
Shares of Sun Pharmaceutical Industries and Ranbaxy Laboratories are trading higher by 2 percent. Sun Pharma stock surged 2 percent […]
Hospitals and Doctors get oxygen from Health Startups
As more people go online to find, consult and stay in touch with doctors, it is proving to be a […]
Ranbaxy to pay $ 500 M penalty to US govt to settle lawsuits
India’s largest generic drug manufacturer, has agreed to pay $500 million to the United States and individual States to resolve […]
Abbott India Q1 net up 17% at Rs 31.70 cr
Drug firm Abbott India aid its net profit rose by 17.06 per cent to Rs 31.70 crore for the first […]
Fortis Healthcare to raise $100 million from World Bank arm
India’s largest hospital chain Fortis Healthcare will raise $100 million ( 540 crore) from International Finance Corporation ( IFC). Washington, […]
Imported Insulin to cost more
The National Pharma Pricing Authority, the drug regulators have received a deadline of two months to revise its November order […]
Novartis loses Indian patent case
India’s Supreme Court has rejected a plea by Novartis to patent an updated version of its cancer drug, Glivec. The […]
The changing scenario of Healthcare IT in 2013
Every New Year brings the promise of change, but even though it’s still early, when it comes to the world […]
Design a Modern Tricorder and You Could Win USD10 Million from the X Prize Foundation!
Any guess, any idea, any vision about the future of medical technology ? It will be something close to slick […]
Drug prices continue to remain out of control
The proposed drug pricing policy is riddled with a host of anomalies. Extending price control to all “essential” medicines will […]
Drug Policy a bitter pill for low cost players
Companies currently selling essential medicines at less than the government-mandated price caps will have to freeze their rates at […]
